background
novel
promis
medicin
biolog
impact
mammalian
reproduct
system
systemat
studi
aim
studi
evalu
effect
sperm
paramet
spermatogenesi
mice
studi
synthes
accord
report
adult
male
mice
randomli
segreg
four
group
group
group
set
control
group
group
administ
daili
dose
gmous
respect
intraperiton
inject
day
day
last
inject
test
cauda
epididymid
collect
stain
sperm
concentr
motil
morpholog
analysi
result
indic
treat
total
sperm
count
motil
sperm
rate
show
downward
trend
abnorm
sperm
rate
show
increas
trend
compar
control
group
daili
dose
gmous
caus
signific
decreas
sperm
concentr
motil
signific
increas
abnorm
sperm
rate
gmous
drug
treatment
lead
signific
decreas
sperm
motil
increas
abnorm
sperm
rate
stain
testicular
epididym
tissu
show
spermatogenesi
mice
significantli
deterior
increas
dosag
especi
gmous
group
find
suggest
high
dosag
may
induc
testicular
toxic
result
deterior
sperm
paramet
mice
investig
reproduct
toxic
requir
global
epidem
corona
viru
diseas
impact
lifestyl
billion
peopl
differ
region
outbreak
case
remdesivir
develop
code
novel
nucleosid
analogu
antivir
drug
use
treatment
patient
howev
nucleosid
analogu
drug
potenti
toxic
gametogenesi
embryo
develop
gonad
function
among
nucleosid
analogu
drug
studi
purin
prove
purinerg
signal
involv
hormon
secret
penil
erect
sperm
motil
capacit
mucou
product
similar
competitor
adenosin
triphosph
atp
competit
combin
inhibit
rna
depend
rna
polymeras
rdrp
mani
rna
virus
includ
fibroviru
ebola
coronaviru
flavivirida
hepat
c
viru
therebi
inhibit
viru
replic
remdesivir
novel
promis
medicin
gain
orphan
drug
design
fda
howev
potenti
biolog
toxic
nucleosid
analogu
drug
far
well
evalu
antivir
drug
includ
acyclovir
ribavirin
shown
teratogen
effect
addit
continu
highdos
administr
caus
decreas
semen
qualiti
rat
develop
testicular
sertoli
cell
prostat
semin
vesicl
slow
abund
testosteron
serum
also
decreas
human
reproduct
system
highli
sensit
chemic
due
totipot
germ
cell
effect
may
magnifi
gamet
fertil
embryo
develop
result
huge
impact
progeni
therefor
consider
reproduct
safeti
patient
offspr
cytotox
genotox
mammalian
reproduct
system
systemat
studi
studi
male
mice
g
kept
specif
condit
h
lightdark
cycl
room
temperatur
enough
food
water
suppli
mice
approv
accord
guidanc
institut
ethic
committe
synthes
accord
previou
report
product
character
hydrogen
nuclear
magnet
reson
h
nmr
bruker
magnet
system
karlsruh
germani
mm
mass
spectrum
ms
water
lcm
system
milford
usa
confirm
structur
puriti
three
dose
level
gmous
drug
use
intraperiton
inject
dissolv
steril
salin
day
drug
dissolv
salin
solut
inject
mice
randomli
segreg
group
seven
group
set
control
group
treat
steril
salin
inject
without
drug
group
administ
gmouseday
drug
respect
group
treat
intraperiton
inject
consecut
day
day
last
treatment
mice
sacrif
co
inhal
co
incub
min
allow
sperm
swim
collect
sperm
count
hemocytometri
neubauer
chamber
relat
detail
referenc
manual
sperm
head
count
millionml
concentr
l
sperm
suspens
prepar
morpholog
analysi
smear
evalu
abnorm
shape
rate
diffquik
solarbio
scienc
technolog
co
ltd
beij
china
stain
use
determin
sperm
morpholog
min
fix
fix
smear
stain
solut
b
h
separ
dri
smear
observ
magnif
exam
sperm
per
mous
morpholog
anomali
divid
amorph
head
hookless
banana
doublehead
coil
microcephali
bent
cephalocaud
junction
bent
project
filament
microcephali
tail
defect
defect
head
duplic
tail
sperm
classifi
motil
immotil
magnif
microscop
olympu
tokyo
japan
least
random
field
sperm
examin
determin
motil
rate
motil
present
percentag
motil
sperm
total
number
sperm
right
test
epididymid
collect
surgic
remov
fat
tissu
fix
bouin
fluid
solarbio
scienc
technolog
co
ltd
beij
china
observ
histolog
fix
testicular
epididym
tissu
paraffinembed
slice
thick
hematoxylineosin
stain
observ
microscop
photograph
find
chang
spermatogen
epitheli
structur
test
sperm
store
epididymid
experiment
data
process
spss
statist
softwar
result
express
mean
sem
pair
test
independ
test
use
comparison
group
p
consid
statist
signific
product
character
fig
puriti
product
synthes
use
subsequ
experi
certifi
peer
review
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
version
post
april
concentr
morpholog
motil
sperm
cauda
epididymi
evalu
reproduct
toxic
assay
result
indic
treat
drug
total
sperm
count
motil
sperm
rate
show
downward
trend
abnorm
sperm
rate
show
increas
trend
fig
g
drug
caus
signific
decreas
sperm
b
certifi
peer
review
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
version
post
april
http
doi
biorxiv
preprint
concentr
fig
p
motil
fig
p
group
compar
control
group
group
abnorm
sperm
rate
group
significantli
higher
group
fig
p
g
drug
treatment
lead
signific
decreas
sperm
motil
fig
p
increas
abnorm
sperm
rate
fig
p
compar
group
observ
analysi
morpholog
abnorm
caus
highdos
drug
perform
compar
control
group
group
fig
abnorm
sperm
highdos
group
group
show
abnorm
head
condit
fig
includ
headless
small
head
abnorm
head
shape
addit
g
drugtreat
group
group
proport
type
abnorm
sperm
increas
significantli
includ
bodi
fig
tail
fig
overal
abnorm
fig
summari
sperm
paramet
present
neg
effect
drug
dosedepend
manner
certifi
peer
review
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
version
post
april
http
doi
biorxiv
preprint
drugtreat
group
g
h
overal
abnorm
sperm
drugtreat
group
order
studi
testicular
spermatogenesi
treat
mice
testicular
tissu
group
collect
stain
micromorpholog
observ
johnsen
score
evalu
use
determin
effect
testicular
spermatogenesi
result
show
compar
control
group
normal
spermatogenesi
score
stain
result
group
show
g
drug
signific
effect
testicular
function
fig
spermatogenesi
g
group
group
chang
slightli
mani
late
stage
sperm
cell
sperm
seminifer
tubul
arrang
disord
exfoli
spermatogen
cell
lumen
fig
score
highest
dose
group
g
drug
group
significantli
affect
microscop
observ
late
stage
sperm
cell
sperm
greatli
reduc
even
disappear
earli
sperm
cell
less
disappear
fig
even
fibrosi
testicular
tissu
cell
structur
disappear
fig
score
observ
sperm
distribut
epididym
tissu
slice
reveal
high
concentr
sperm
epididym
duct
group
fig
epididym
sperm
concentr
group
slightli
reduc
overal
concentr
still
high
fig
sperm
concentr
group
significantli
reduc
seen
occasion
fig
even
invis
fig
result
basic
consist
result
sperm
paramet
observ
certifi
peer
review
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
version
post
april
http
doi
biorxiv
preprint
develop
process
remdesivir
took
sever
year
structur
design
ribos
skeleton
take
account
effici
combin
rdrp
well
better
chemic
stabil
present
still
systemat
studi
reproduct
toxic
report
rel
strong
select
rdrp
bind
bind
viru
bind
anim
host
cell
addit
metabol
studi
primat
show
drug
remain
testicular
tissu
earli
stage
medic
time
drug
metabol
testicular
tissu
also
rel
fast
april
clinic
studi
patient
reveal
clinic
improv
day
medic
side
effect
also
highlight
includ
patient
elev
liver
enzym
diarrhea
rash
renal
dysfunct
hypertens
total
patient
experienc
sever
side
effect
includ
multipl
organ
dysfunct
syndrom
septic
shock
acut
kidney
injuri
hypertens
studi
effect
male
mice
reproduct
function
provid
refer
possibl
reproduct
toxic
human
current
recommend
intraven
administr
human
accord
clinic
guidelin
due
limit
water
solubl
mgml
mice
administ
intraperiton
inject
larg
volum
inject
studi
gener
dosag
administ
human
mgpersonday
convert
bodyweight
dose
mgkgday
studi
use
dose
gmouseday
mice
convert
mgkgday
bodyweight
dose
intermedi
dose
gmouseday
close
human
dose
continu
administ
day
measur
day
stop
medicin
sperm
concentr
epididymid
chang
significantli
spermatogenesi
test
slightli
decreas
motil
epididym
sperm
decreas
significantli
proport
abnorm
sperm
increas
significantli
result
show
b
certifi
peer
review
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
version
post
april
http
doi
biorxiv
preprint
regular
dose
medic
patient
may
need
longer
time
restor
spermatogenesi
ensur
reproduct
safeti
obtain
healthi
offspr
lower
concentr
drug
group
gmouseday
paramet
signific
differ
compar
control
group
gmouseday
studi
highest
dose
group
gmouseday
found
paramet
group
significantli
affect
sperm
concentr
motil
epididym
duct
group
significantli
reduc
proport
abnorm
sperm
significantli
increas
testicular
epididym
tissu
slice
show
spermatogenesi
mice
significantli
affect
testicular
tissu
appear
fibrosi
loss
function
sperm
epididymid
also
significantli
reduc
even
disappear
result
indic
continu
highdos
gmouseday
use
day
could
advers
affect
spermatogen
sperm
paramet
test
male
mice
effect
would
recov
within
week
stop
medicin
summari
control
dosag
interv
drug
withdraw
fertil
key
consider
reduc
reproduct
toxic
offspr
malform
risk
one
drug
candid
epidem
mainli
exert
antivir
therapeut
effect
viru
report
viru
damag
effect
male
reproduct
system
kidney
orchiti
caus
steril
balanc
treatment
reproduct
damag
caus
virus
reproduct
toxic
caus
drug
may
interest
research
content
howev
critic
ill
patient
mostli
elderli
patient
reproduct
system
function
may
weaken
age
longer
mainten
focu
may
necessari
pay
attent
assess
reproduct
toxic
medic
young
childbear
peopl
find
suggest
high
dosag
may
induc
testicular
toxic
result
deterior
sperm
paramet
male
mice
current
intern
epidem
situat
get
wors
wide
use
intern
firstlin
treatment
drug
research
reproduct
toxicolog
need
indepth
